Group One Trading
BHVN

Group One Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Group One Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-86,600
Closed -$13.1M – 8575
2022
Q3 		$13.1M Buy
86,600
+30,300
+54% +$4.49M 0.03% 586
2022
Q2 		$8.2M Buy
56,300
+39,100
+227% +$4.99M 0.01% 977
2022
Q1 		$2.04M Sell
17,200
-4,200
-20% -$524K ﹤0.01% 2378
2021
Q4 		$2.95M Sell
21,400
-36,900
-63% -$4.69M ﹤0.01% 2199
2021
Q3 		$8.1M Buy
58,300
+19,300
+49% +$2.41M 0.01% 1240
2021
Q2 		$3.79M Sell
39,000
-500
-1% -$40.6K ﹤0.01% 1968
2021
Q1 		$2.7M Sell
39,500
-24,000
-38% -$1.94M ﹤0.01% 2138
2020
Q4 		$5.44M Buy
63,500
+7,600
+14% +$644K 0.01% 1210
2020
Q3 		$3.63M Buy
55,900
+12,200
+28% +$800K 0.01% 1132
2020
Q2 		$3.19M Sell
43,700
-57,300
-57% -$3.05M 0.01% 1125
2020
Q1 		$3.44M Sell
101,000
-72,700
-42% -$3.32M 0.03% 723
2019
Q4 		$9.46M Buy
173,700
+7,800
+5% +$386K 0.06% 370
2019
Q3 		$6.92M Sell
165,900
-4,400
-3% -$186K 0.06% 422
2019
Q2 		$7.46M Buy
170,300
+35,500
+26% +$2M 0.07% 343
2019
Q1 		$6.94M Sell
134,800
-300
-0.2% -$13K 0.08% 297
2018
Q4 		$5M Buy
135,100
+129,800
+2,449% +$4.68M 0.04% 512
2018
Q3 		$199K Buy
+5,300
New +$195K ﹤0.01% 3019
2018
Q2 		– Sell
-25,000
Closed -$644K – 5874
2018
Q1 		$644K Buy
+25,000
New +$747K 0.01% 1854

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Group One Trading's BHVN Position: Q3 2022 in Review

Group One Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 3,881 shares — an estimated $575K sold.

Group One Trading first reported a position in BHVN in Q1 2018 and held it in 12 quarters. The position peaked at $4.5M in Q2 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Group One Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 3,881 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $575K.
  • Group One Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 12 quarters.
  • Group One Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4.5M in Q2 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.